{
    "code": "06020348",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06020348",
    "time": "2020-02-25 19:56:53",
    "許可證字號": "衛署醫器輸字第020348號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD3643",
    "有效日期": "113\/06\/29",
    "發證日期": "98\/06\/29",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00602034802",
    "中文品名": "亞培設計師C-胜呔檢驗試劑組",
    "英文品名": "ABBOTT ARCHITECT C-Peptide",
    "效能": "ARCHITECT C-Peptide分析是一種體外化學冷光微粒免疫分析法 (CMIA)，可用於ARCHITECT i 系統上定量測試人類血清、血漿及尿液中之C-胜&#32957; (C-peptide)。ARCHITECT C-Peptide分析可用於輔助診斷及治療包含糖尿病在內之胰島素分泌異常的患者。",
    "醫器規格": "# 3L53-25：100 tests, # 3L53-01, #3L53-10",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A1135胰島素前質C-?類試驗系統",
    "醫器主類別二": "A臨床化學及臨床毒理學",
    "醫器次類別二": "A1150校正品",
    "醫器主類別三": "A臨床化學及臨床毒理學",
    "醫器次類別三": "A1660品管材料(分析與非分析)",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入 09委託製造",
    "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": {
        "製造廠名稱": "MES0020000  BIOKIT S.A.",
        "製造廠廠址": "CAN MALE S\/N 08186 LLICA D&#39;AMUNT, BARCELONA, SPAIN",
        "製造廠公司地址": "",
        "製造廠國別": "SPAIN",
        "製程": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060203480001-102-12-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06020348&Seq=001&Type=9"
        }
    ]
}